According to Ampio Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 0.0852.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 0.5076 | 76.15% |
2022-12-31 | 0.2882 | -93.93% |
2021-12-31 | 4.75 | -71.76% |
2020-12-31 | 16.8 | 17.05% |
2019-12-31 | 14.4 | 71.61% |
2018-12-31 | 8.37 | -192.5% |
2017-12-31 | -9.04 | -216.56% |
2016-12-31 | 7.76 | 61.69% |
2015-12-31 | 4.80 | 76.2% |
2014-12-31 | 2.72 | -69.84% |
2013-12-31 | 9.03 | 61.95% |
2012-12-31 | 5.58 | -19.49% |
2011-12-31 | 6.93 | -167.61% |
2010-12-31 | -10.2 | 96.81% |
2009-12-31 | -5.20 | -83.63% |
2008-12-31 | -31.8 | |
2007-12-31 | N/A | |
2006-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 5.25 | 6,061.13% | ๐บ๐ธ USA |
Pfizer PFE | 1.76 | 1,963.02% | ๐บ๐ธ USA |
Abbott Laboratories ABT | 4.73 | 5,458.98% | ๐บ๐ธ USA |
Regeneron Pharmaceuticals REGN | 3.98 | 4,571.22% | ๐บ๐ธ USA |
Rigel Pharmaceuticals RIGL | -7.04 | -8,370.12% | ๐บ๐ธ USA |